• Publications
  • Influence
Marked Differences in CNS Activity among EGFR Inhibitors: Case Report and Mini-Review.
Marked Differences in CNS Activity among EGFR Inhibitors: Case Report and Mini-Review Vipul Pareek, MD, Mary Welch, MD, Elizabeth Ravera, RN, Richard L. Zampolin, MD, Lecia V. Sequist, MD, BalazsExpand
  • 6
  • 1
Comparison of 99m Tc- Ethylene Dicysteine and 99m Tc-Dimercaptosuccinic Acid Scintigraphy for the Evaluation of Cortical Scarring and Differential Renal Function in Children with Recurrent Urinary
Introduction: Urinary tract infection (UTI) is the most common and severe bacterial infection in children. Renal scarring and associated deterioration in the differential renal function is a frequentExpand
  • 1
  • 1
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies.
Tumor immune evasion is one of the hallmarks of cancer, and expression of the B7 family of immune checkpoints (PD-L1, PD-L2, B7-H3, B7x and HHLA2) is one mechanism of immune evasion by tumors toExpand
  • 36
  • PDF
Progress in extracellular vesicle biology and their application in cancer medicine
Abstract Under the broader category of extracellular vesicles (EVs), exosomes are now well recognized for their contribution and potential for biomedical research. During the last ten years, numerousExpand
  • 6
Emerging treatment for ALK-positive lung cancer
ABSTRACT Introduction: Lung cancer is associated with poor prognosis and limited benefit from chemotherapy. The treatment of non-small cell lung cancer (NSCLC) has been revolutionized by theExpand
  • 2
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
BACKGROUND Pancreatic neuroendocrine tumors (panNETs) are a rare group of tumors that make up 2%-3% of pancreatic tumors. Recommended treatment for panNETs generally consists of resection forExpand
  • 3
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
BACKGROUND Pancreatic neuroendocrine tumors (panNETs) are a rare group of tumors that make up 2%-3% of pancreatic tumors. Recommended treatment for panNETs generally consists of resection forExpand
  • 3
Distinguishing head and neck cancer metastasis from second primary squamous lung cancer in the genomic era.
e17506Background: Patients with head and neck squamous cell carcinoma (HNSCC) are at risk for both lung metastases and secondary primary cancers of the lung. Given the histopathologic similarityExpand
  • 1
Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?
Abstract 1453 Approximately 140,000 patients per year are diagnosed with colorectal cancer in the United States. Historically, treatment modalities have included surgery, 5-fluourouracil (5-FU)Expand
  • 1